Annual Shareholders Equity
$224.09 M
+$1.74 M+0.78%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual stockholders equity is $224.09 million, with the most recent change of +$1.74 million (+0.78%) on December 31, 2023.
- During the last 3 years, ORIC annual shareholders equity has fallen by -$65.69 million (-22.67%).
- ORIC annual shareholders equity is now -22.67% below its all-time high of $289.78 million, reached on December 31, 2020.
Performance
ORIC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$273.99 M
-$28.41 M-9.39%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly stockholders equity is $273.99 million, with the most recent change of -$28.41 million (-9.39%) on September 30, 2024.
- Over the past year, ORIC quarterly shareholders equity has increased by +$26.58 million (+10.74%).
- ORIC quarterly shareholders equity is now -16.63% below its all-time high of $328.64 million, reached on March 31, 2024.
Performance
ORIC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ORIC Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.8% | +10.7% |
3 y3 years | -22.7% | +10.7% |
5 y5 years | +447.8% | +10.7% |
ORIC Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -17.9% | +0.8% | -16.6% | +35.1% |
5 y | 5-year | -22.7% | +348.8% | -16.6% | +378.4% |
alltime | all time | -22.7% | +348.8% | -16.6% | +378.4% |
ORIC Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $273.99 M(-9.4%) |
Jun 2024 | - | $302.40 M(-8.0%) |
Mar 2024 | - | $328.64 M(+46.7%) |
Dec 2023 | $224.09 M(+0.8%) | $224.09 M(-9.4%) |
Sep 2023 | - | $247.41 M(-8.0%) |
Jun 2023 | - | $268.80 M(+32.5%) |
Mar 2023 | - | $202.81 M(-8.8%) |
Dec 2022 | $222.35 M | $222.35 M(+3.5%) |
Sep 2022 | - | $214.82 M(-9.3%) |
Jun 2022 | - | $236.87 M(-6.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $253.08 M(-7.3%) |
Dec 2021 | $272.98 M(-5.8%) | $272.98 M(-6.4%) |
Sep 2021 | - | $291.54 M(+12.9%) |
Jun 2021 | - | $258.32 M(-6.4%) |
Mar 2021 | - | $276.07 M(-4.7%) |
Dec 2020 | $289.78 M(-421.7%) | $289.78 M(+57.2%) |
Sep 2020 | - | $184.38 M(-5.6%) |
Jun 2020 | - | $195.25 M(-298.4%) |
Mar 2020 | - | -$98.42 M(+9.3%) |
Dec 2019 | -$90.08 M(+39.8%) | -$90.08 M |
Dec 2018 | -$64.43 M | - |
FAQ
- What is ORIC Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual shareholders equity year-on-year change?
- What is ORIC Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly shareholders equity year-on-year change?
What is ORIC Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ORIC is $224.09 M
What is the all time high annual shareholders equity for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual stockholders equity is $289.78 M
What is ORIC Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ORIC annual stockholders equity has changed by +$1.74 M (+0.78%)
What is ORIC Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ORIC is $273.99 M
What is the all time high quarterly shareholders equity for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly stockholders equity is $328.64 M
What is ORIC Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ORIC quarterly stockholders equity has changed by +$26.58 M (+10.74%)